The Project Quit team is currently conducting a half–dozen research studies aimed at both ...Read More
Quitting smoking is hard. Addiction experts at MUSC Hollings Cancer Center...Read More
Even with all the anti–smoking campaigns and efforts to stop tobacco companies…Read More
New article/feature with Charleston Animal Society on page 7…Read More
A Randomized Controlled Trial of Varenicline for Adolescent Smoking Cessation
Adolescent Cessation Study (the original Project Quit Study)
Dr. Kevin Gray
This is a research study to determine if a medication (varenicline) helps young cigarette smokers quit. Smokers aged 14-21 who participate in the study receive medication or placebo and help with quitting during 12 weekly sessions. Smokers under 18 must have parental consent.
Gender Differences in Latency to Smoke Following Exposure to Stressful and Smoking Cues in Daily Life
SCOR 3.5 Nicotine Pilot
Dr. Rachel Tomko (Mentor: Dr. Kevin Gray)
Smokers, ages 18-45, are being recruited for a non-treatment research study to help better understand patterns of cigarette smoking among male and female regular smokers. Specifically, participants will track their cigarette use using an electronic lighter and complete surveys on a mobile device for two weeks.
Translational Neuropsychopharmacology Research of Nicotine Addiction
Drs. Brett Froeliger and Kevin Gray
This study is investigating the effects of combining 2 medications, Varenicline (commonly known as Chantix®) and N-acetylcysteine, on smoking behavior in daily cigarette smokers who are interested in quitting smoking. The study consists of 10 visits over 6 weeks. Smokers must be between the ages of 18 and 55.
Evaluating N-acetylcysteine as a pharmacotherapy for tobacco use disorder
NAC for TUD
Dr. Erin McClure
The purpose of this study is to assess the effects of N-Acetylcysteine (NAC), an over-the-counter antioxidant, to assist adult cigarette smokers with quitting and preventing relapse to smoking. This medication may help people quit smoking by reducing withdrawal symptoms, craving, and preventing relapse, but we do not know if NAC helps smokers early in their quit attempt or after they have already quit.
Evaluating smoking and relapse in adolescents and emerging adults using remote monitoring technology**
Dr. Erin McClure
This is a research study that will test a new remote monitoring technology to assess smoking in the natural environment among adolescents and young adults ages 15-25. After assessment and inclusion in the study, participants will be asked to report on their smoking by answering questions on a mobile phone for 35 days. Participants will also be asked to make a brief quit attempt lasting for approximately 48 hours.
Personalized Smoking Relapse Prevention Delivered in Real-Time via Just-in-Time-Adaptive Interventions: Integrated Tobacco Retail Outlet Location
The QuitBuddy Study
Dr. Bryan Heckman
The QuitBuddy Study involves use of a new quit-smoking smartphone application. Participants will use the app for two weeks, which involves completing surveys several times a day (approx. 15 min each) and logging any smoking activity. Participants will need to make a nicotine replacement medicine (over-the-counter and study provided) aided quit-attempt. Participants will have the opportunity to make suggestions that may improve the development of the app.